top of page

Project Optimus Support

We have extensive knowledge and experience in oncology and Project Optimus requirements. We have defended clients successfully in selecting their RP2D:

Design your Phase 1A (dose escalation) and Phase 1B (dose Optimization) studies

Perform the population PK, categorical and Exposure-Response analyses needed to select the RP2D

Write the FDA Briefing Document including a strong defense of your RP2D selection 

Attend the Type B meeting to defend your RP2D

bottom of page